U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06907680) titled 'M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis' on March 27.
Brief Summary: The goal of this clinical trial is to assess the efficacy and safety of M-Gard supplementation for alleviating the symptoms of allergic rhinitis.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Allergic Rhinitis Due to Grass Pollens
Intervention:
DIETARY_SUPPLEMENT: M-Gard
One capsule containing 250mg of M-Gard Particulate EW is taken twice daily for 14 days.
OTHER: Placebo
One capsule containing 250mg of MCC (Microcrystalline Cellulose) is taken twice daily for 14 days.
Recruitment Status: NOT_YET_RECRUITING
...